Lineage Cell Therapeutics, Inc. (LCTX)

NYSEAMERICAN: LCTX · IEX Real-Time Price · USD

1.200

-0.090 (-6.98%)

At close: Apr 18, 2024, 4:00 PM

1.240

+0.040 (3.33%)

After-hours: Apr 18, 2024, 4:15 PM EDT

Lineage Cell Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1996
Net Income	-21.49	-26.27	-43.02	-20.65	-11.71	-45.99	-19.98	33.57	-47.41	-36.5	Upgrade
Depreciation & Amortization	0.69	0.73	0.87	2.11	3.13	3.27	3.3	4.76	6.33	8.41	Upgrade
Share-Based Compensation	4.64	4.29	3.72	2.35	3.58	5.4	3.93	7.95	11.05	4.46	Upgrade
Other Operating Activities	-12.41	22.32	14.86	-3.56	-26.95	6.43	-17.77	-88.61	-14.94	-15.31	Upgrade
Operating Cash Flow	-28.57	1.06	-23.56	-19.75	-31.95	-30.88	-30.52	-42.33	-44.54	-38.85	Upgrade
Capital Expenditures	-0.67	-0.41	-0.34	-0.04	-0.36	-1.42	-1.13	-2.53	-5.33	-0.69	Upgrade
Acquisitions	0	0	10.09	13.06	17.33	11.9	-8.9	-8.38	0	0	Upgrade
Change in Investments	47.12	-45.75	0	0	0	3.22	-0.19	0	-1.25	0	Upgrade
Other Investing Activities	-	-	-	0.02	-0.02	-1.88	-0.01	0.01	-0.86	-0.32	Upgrade
Investing Cash Flow	46.45	-46.16	9.75	13.04	16.96	11.82	-10.23	-10.89	-7.44	-1.01	Upgrade
Share Issuance / Repurchase	6.59	0.13	30.81	5.1	-0.01	-0.2	48.85	20.13	36.11	59.53	Upgrade
Debt Issued / Paid	-0.05	-0.03	-0.02	25.12	-0.1	-0.35	0.17	1.61	0.2	0.45	Upgrade
Other Financing Activities	-0.11	1.53	6.14	-0.36	0.72	6.33	6.37	11.05	28.47	3.65	Upgrade
Financing Cash Flow	6.42	1.63	36.93	29.87	0.62	5.77	55.39	32.78	64.78	63.62	Upgrade
Exchange Rate Effect	-0.25	-0.87	-0.02	-0.06	0.07	0.01	0.1	0.29	-0.05	0.23	Upgrade
Net Cash Flow	24.06	-44.34	23.09	23.09	-14.3	-13.29	14.75	-20.14	12.74	23.99	Upgrade
Free Cash Flow	-29.24	0.65	-23.9	-19.79	-32.31	-32.3	-31.64	-44.85	-49.88	-39.55	Upgrade
Free Cash Flow Margin	-326.89%	4.39%	-550.59%	-1084.01%	-919.06%	-647.49%	-915.07%	-757.25%	-708.90%	-754.14%	Upgrade
Free Cash Flow Per Share	-0.17	0.00	-0.14	-0.13	-0.22	-0.26	-0.28	-0.46	-0.63	-0.59	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).